G2/M cell cycle arrest correlates with primate lentiviral Vpr interaction with the SLX4 complex

Journal of Virology

Volumn 89, Issue 1, 2015, Pages 230-240

  Berger, Gregory ^a   Lawrence, Madeleine ^a   Hué, Stephane ^b   Neil, Stuart J D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP P PROTEIN; SMALL INTERFERING RNA; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; VPR PROTEIN; RECOMBINASE;

ANIMAL CELL; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CONTROLLED STUDY; HEK293 CELL LINE; HELA CELL LINE; HUMAN; HUMAN CELL; NONHUMAN; PHENOTYPE; PHYLOGENY; PLASMID; PROTEIN DEPLETION; PROTEIN INTERACTION; SIMIAN IMMUNODEFICIENCY VIRUS; ANIMAL; CELL CYCLE CHECKPOINT; CELL LINE; CERCOPITHECINAE; HOST PATHOGEN INTERACTION; METABOLISM; PHYSIOLOGY;

CERCOPITHECUS AETHIOPS; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIMATES; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CELL CYCLE CHECKPOINTS; CELL LINE; CERCOPITHECINAE; GENE PRODUCTS, VPR; HOST-PATHOGEN INTERACTIONS; HUMANS; RECOMBINASES; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 84919458593     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02307-14     Document Type: Article

References (43)

1. Selig L, Pages JC, Tanchou V, Preveral S, Berlioz-Torrent C, Liu LX, Erdtmann L, Darlix J, Benarous R, Benichou S. 1999. Interaction with the p6 domain of the gag precursor mediates incorporation into virions of Vpr and Vpx proteins from primate lentiviruses. J Virol 73:592-600.
2. Kondo E, Mammano F, Cohen EA, Gottlinger HG. 1995. The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J Virol 69:2759-2764.
3. Stivahtis GL, Soares MA, Vodicka MA, Hahn BH, Emerman M. 1997. Conservation and host specificity of Vpr-mediated cell cycle arrest suggest a fundamental role in primate lentivirus evolution and biology. J Virol 71:4331-4338.
4. Planelles V, Jowett JB, Li QX, Xie Y, Hahn B, Chen IS. 1996. Vprinduced cell cycle arrest is conserved among primate lentiviruses. J Virol 70:2516-2524.
5. Ayinde D, Maudet C, Transy C, Margottin-Goguet F. 2010. Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?. Retrovirology 7:35. http://dx.doi.org/10.1186/1742-4690-7-35.
6. Goh WC, Rogel ME, Kinsey CM, Michael SF, Fultz PN, Nowak MA, Hahn BH, Emerman M. 1998. HIV-1 Vpr increases viral expression by manipulation of the cell cycle: a mechanism for selection of Vpr in vivo. Nat Med 4:65-71. http://dx.doi.org/10.1038/nm0198-065.
7. Lim ES, Fregoso OI, McCoy CO, Matsen FA, Malik HS, Emerman M. 2012. The ability of primate lentiviruses to degrade the monocyte restriction factorSAMHD1preceded the birth of the viral accessory protein Vpx. Cell Host Microbe 11:194-204. http://dx.doi.org/10.1016/j.chom.2012.01.004.
8. Tristem M, Marshall C, Karpas A, Hill F. 1992. Evolution of the primate lentiviruses: evidence from vpx and vpr. EMBO J 11:3405-3412.
9. Spragg CJ, Emerman M. 2013. Antagonism of SAMHD1 is actively maintained in natural infections of simian immunodeficiency virus. Proc Natl Acad Sci USA 110:21136-21141. http://dx.doi.org/10.1073/pnas.1316839110.
10. Laguette N, Sobhian B, Casartelli N, Ringeard M, Chable-Bessia C, Segeral E, Yatim A, Emiliani S, Schwartz O, Benkirane M. 2011. SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474:654-657. http://dx.doi.org/10.1038/nature10117.
11. Le Rouzic E, Belaidouni N, Estrabaud E, Morel M, Rain JC, Transy C, Margottin-Goguet F. 2007. HIV1 Vpr arrests the cell cycle by recruiting DCAF1/VprBP, a receptor of the Cul4-DDB1 ubiquitin ligase. Cell Cycle 6:182-188. http://dx.doi.org/10.4161/cc.6.2.3732.
12. Schröfelbauer B, Hakata Y, Landau NR. 2007. HIV-1 Vpr function is mediated by interaction with the damage-specific DNA-binding protein DDB1. Proc Natl Acad Sci USA 104:4130-4135. http://dx.doi.org/10.1073/pnas.0610167104.
13. Roshal M, Kim B, Zhu Y, Nghiem P, Planelles V. 2003. Activation of the ATR-mediated DNA damage response by the HIV-1 viral protein R. J Biol Chem 278:25879-25886. http://dx.doi.org/10.1074/jbc.M303948200.
14. Belzile JP, Richard J, Rougeau N, Xiao Y, Cohen EA. 2010. HIV-1 Vpr induces the K48-linked polyubiquitination and proteasomal degradation of target cellular proteins to activate ATR and promote G2 arrest. J Virol 84:3320-3330. http://dx.doi.org/10.1128/JVI.02590-09.
15. Laguette N, Bregnard C, Hue P, Basbous J, Yatim A, Larroque M, Kirchhoff F, Constantinou A, Sobhian B, Benkirane M. 2014. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 156:134-145. http://dx.doi.org/10.1016/j.cell.2013.12.011.
16. Garner E, Kim Y, Lach FP, Kottemann MC, Smogorzewska A. 2013. Human GEN1 and the SLX4-associated nucleases MUS81 and SLX1 are essential for the resolution of replication-induced Holliday junctions. Cell Rep 5:207-215. http://dx.doi.org/10.1016/j.celrep.2013.08.041.
17. Wyatt HD, Sarbajna S, Matos J, West SC. 2013. Coordinated actions of SLX1-SLX4 and MUS81-EME1 for Holliday junction resolution in human cells. Mol Cell 52:234-247. http://dx.doi.org/10.1016/j.molcel.2013.08.035.
18. Schaller T, Pollpeter D, Apolonia L, Goujon C, Malim MH. 2014. Nuclear import of SAMHD1 is mediated by a classical karyopherin alpha/beta1 dependent pathway and confers sensitivity to VpxMAC induced ubiquitination and proteasomal degradation. Retrovirology 11:29. http://dx.doi.org/10.1186/1742-4690-11-29.
19. Svendsen JM, Smogorzewska A, Sowa ME, O'Connell BC, Gygi SP, Elledge SJ, Harper JW. 2009. Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair. Cell 138:63-77. http://dx.doi.org/10.1016/j.cell.2009.06.030.
20. Ward J, Davis Z, DeHart J, Zimmerman E, Bosque A, Brunetta E, Mavilio D, Planelles V, Barker E. 2009. HIV-1 Vpr triggers natural killer cell-mediated lysis of infected cells through activation of the ATRmediated DNA damage response. PLoS Pathog 5:e1000613. http://dx.doi.org/10.1371/journal.ppat.1000613.
21. Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NM, Orr AI, Reaper PM, Jackson SP, Curtin NJ, Smith GC. 2004. Identification and characterization of a novel and specific inhibitor of the ataxiatelangiectasia mutated kinase ATM. Cancer Res 64:9152-9159. http://dx.doi.org/10.1158/0008-5472.CAN-04-2727.
22. Goujon C, Arfi V, Pertel T, Luban J, Lienard J, Rigal D, Darlix JL, Cimarelli A. 2008. Characterization of simian immunodeficiency virus SIVSM/human immunodeficiency virus type 2 Vpx function in human myeloid cells. J Virol 82:12335-12345. http://dx.doi.org/10.1128/JVI.01181-08.
23. Price MN, Dehal PS, Arkin AP. 2010. FastTree 2-approximately maximum-likelihood trees for large alignments. PLoS One 5:e9490. http://dx.doi.org/10.1371/journal.pone.0009490.
24. Telenti A, Johnson WE. 2012. Host genes important to HIV replication and evolution. Cold Spring Harb Perspect Med 2:a007203. http://dx.doi.org/10.1101/cshperspect.a007203.
25. Fregoso OI, Ahn J, Wang C, Mehrens J, Skowronski J, Emerman M. 2013. Evolutionary toggling of Vpx/Vpr specificity results in divergent recognition of the restriction factor SAMHD1. PLoS Pathog 9:e1003496. http://dx.doi.org/10.1371/journal.ppat.1003496.
26. Laguette N, Rahm N, Sobhian B, Chable-Bessia C, Munch J, Snoeck J, Sauter D, Switzer WM, Heneine W, Kirchhoff F, Delsuc F, Telenti A, Benkirane M. 2012. Evolutionary and functional analyses of the interaction between the myeloid restriction factor SAMHD1 and the lentiviral Vpx protein. Cell Host Microbe 11:205-217. http://dx.doi.org/10.1016/j.chom.2012.01.007.
27. Maudet C, Bertrand M, Le Rouzic E, Lahouassa H, Ayinde D, Nisole S, Goujon C, Cimarelli A, Margottin-Goguet F, Transy C. 2011. Molecular insight into how HIV-1 Vpr protein impairs cell growth through two genetically distinct pathways. J Biol Chem 286:23742-23752. http://dx.doi.org/10.1074/jbc.M111.220780.
28. Zimmerman ES, Chen J, Andersen JL, Ardon O, Dehart JL, Blackett J, Choudhary SK, Camerini D, Nghiem P, Planelles V. 2004. Human immunodeficiency virus type 1 Vpr-mediated G2 arrest requires Rad17 and Hus1 and induces nuclear BRCA1 and gamma-H2AX focus formation. Mol Cell Biol 24:9286-9294. http://dx.doi.org/10.1128/MCB.24.21.9286-9294.2004.
29. Sharma A, Yilmaz A, Marsh K, Cochrane A, Boris-Lawrie K. 2012. Thriving under stress: selective translation of HIV-1 structural protein mRNA during Vpr-mediated impairment of eIF4E translation activity. PLoS Pathog 8:e1002612. http://dx.doi.org/10.1371/journal.ppat.1002612.
30. Fouchier RA, Meyer BE, Simon JH, Fischer U, Albright AV, Gonzalez-Scarano F, Malim MH. 1998. Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex. J Virol 72:6004-6013.
31. Karttunen H, Savas JN, McKinney C, Chen YH, Yates JR, III, Hukkanen V, Huang TT, Mohr I. 2014. Co-opting the Fanconi anemia genomic stability pathway enables herpesvirus DNA synthesis and productive growth. Mol Cell 55:111-122. http://dx.doi.org/10.1016/j.molcel.2014.05.020.
32. Sloan RD, Wainberg MA. 2011. The role of unintegrated DNA in HIV infection. Retrovirology 8:52. http://dx.doi.org/10.1186/1742-4690-8-52.
33. Ferguson BJ, Mansur DS, Peters NE, Ren H, Smith GL. 2012. DNA-PK is a DNA sensor for IRF-3-dependent innate immunity. Elife 1:e00047. http://dx.doi.org/10.7554/eLife.00047.
34. Cooper A, Garcia M, Petrovas C, Yamamoto T, Koup RA, Nabel GJ. 2013. HIV-1 causes CD4 cell death through DNA-dependent protein kinase during viral integration. Nature 498:376-379. http://dx.doi.org/10.1038/nature12274.
35. Rasaiyaah J, Tan CP, Fletcher AJ, Price AJ, Blondeau C, Hilditch L, Jacques DA, Selwood DL, James LC, Noursadeghi M, Towers GJ. 2013. HIV-1 evades innate immune recognition through specific cofactor recruitment. Nature 503:402-405. http://dx.doi.org/10.1038/nature12769.
36. Jakobsen MR, Bak RO, Andersen A, Berg RK, Jensen SB, Tengchuan J, Laustsen A, Hansen K, Ostergaard L, Fitzgerald KA, Xiao TS, Mikkelsen JG, Mogensen TH, Paludan SR. 2013. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc Natl Acad SciUS A 110:E4571-E4580. http://dx.doi.org/10.1073/pnas.1311669110.
37. Gao D, Wu J, Wu YT, Du F, Aroh C, Yan N, Sun L, Chen ZJ. 2013. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341:903-906. http://dx.doi.org/10.1126/science.1240933.
38. Okumura A, Alce T, Lubyova B, Ezelle H, Strebel K, Pitha PM. 2008. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373:85-97. http://dx.doi.org/10.1016/j.virol.2007.10.042.
39. Sharp PM, Hahn BH. 2011. Origins of HIV and the AIDS pandemic. Cold Spring Harb Perspect Med 1:a006841. http://dx.doi.org/10.1101/cshperspect.a006841.
40. Hrecka K, Hao C, Gierszewska M, Swanson SK, Kesik-Brodacka M, Srivastava S, Florens L, Washburn MP, Skowronski J. 2011. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474:658-661. http://dx.doi.org/10.1038/nature10195.
41. Etienne L, Hahn BH, Sharp PM, Matsen FA, Emerman M. 2013. Gene loss and adaptation to hominids underlie the ancient origin of HIV-1. Cell Host Microbe 14:85-92. http://dx.doi.org/10.1016/j.chom.2013.06.002.
42. Clifford R, Louis T, Robbe P, Ackroyd S, Burns A, Timbs AT, Wright Colopy G, Dreau H, Sigaux F, Judde JG, Rotger M, Telenti A, Lin YL, Pasero P, Maelfait J, Titsias M, Cohen DR, Henderson SJ, Ross MT, Bentley D, Hillmen P, Pettitt A, Rehwinkel J, Knight SJ, Taylor JC, Crow YJ, Benkirane M, Schuh A. 2014. SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage. Blood 123:1021-1031. http://dx.doi.org/10.1182/blood-2013-04-490847.
43. Chatzinikolaou G, Karakasilioti I, Garinis GA. 8 July 2014, posting date. DNA damage and innate immunity: links and trade-offs. Trends Immunol http://dx.doi.org/10.1016/j.it.2014.06.003.